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Abstract
Summary We investigated the incidence trend in all major osteoporotic fractures for the whole country of Denmark between
1995 and 2010. Hip and other osteoporotic fractures declined for the general population and especially among women. But, we
observed some increasing trend among men which needs more attention.
Purpose The trend in osteoporotic fractures is varied across the globe, and there is no updated information in the case of Denmark
for all major osteoporotic fractures (MOF). Thus, we investigated the incidence rates (IRs) of MOF among 50+ adults in
Denmark over the period 1995–2010.
Methods A series of cross-sectional analyses was done using the Danish National Health Service Register. Participants were 50+
adults in the full country Denmark with a MOF between 1995 and 2010. Gender- specific IRs of MOF per 10,000 person years
(PYs) were estimated, in addition to IRs of individual fracture sites (hip, vertebrae, humerus, and radius/ulna), and women-to-
men IR ratios for MOF.
Results A general decline was observed in IRs ofMOF for the whole population (from 169.8 per 10,000 PYs in 1995, to 148.0 in
2010), which was more pronounced among women. Thirty-one and nineteen percent of decline was observed in hip fracture rates
among women and men, respectively. The trend in clinical vertebral fracture was slightly decreasing for women and increasing
for men. The women-to-men rate ratio of MOF decreased noticeably from 2.93 to 2.72 during study period.
Conclusions We observed declining trends in MOF and hip fracture for both sexes. However, a lower rate of decrease of hip
fracture and an increasing trend in vertebral fracture was noticed among men. Considering our observations and the major
economic burden that accompanies this devastating disease, more attention should be paid to MOF, especially in men.
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Introduction
This article was published in error in Archives of Osteoporosis
and has now been retracted [1]. Osteoporosis is a systemic met-
abolic skeletal disease where reduced bonemineral density would
make patients susceptible to fractures, called osteoporotic (OP)
fractures. Based on literature consensus, major osteoporotic frac-
tures (MOF) include mostly hip, clinical vertebral, humerus, and
forearm (radius/ulna) fractures, which altogether are a leading
cause of morbidity and mortality worldwide [2]. OP fractures
incurred 5.8 million lost Disability-Adjusted Life Years
(DALYs) worldwide in the year 2000, of which 51% was repre-
sented by twoWHOworld regions Europe and the Americas [3].
The occurrence of a MOF would not only impact the well-being
and function of a patient, including an elevated mortality risk, but
also has substantial economic consequences [4–9]. It is estimated
that in the year 2011, the associated costs of OP fractures were
€36 billion in Europe, and €1.6 billion in Denmark (including
both direct and productivity costs), and these costs are estimated
to double by 2050 [10, 11].
The predicted increase in OP fractures has been reported in
numerous countries, including the USA, China, and in world-
wide projections (especially developing countries), and is in
large part due to the impending aging trajectory [12–14]. A
recent study in the UK with a relatively long follow-up time
(1990–2012) revealed mostly a rising or steady trend for most
OP fractures in both men and women [15]. However, despite
the expected increase, a number of studies have identified a
leveling, or decline in hip fractures in recent years [16–21].
This led the International Osteoporosis Foundation (IOF) work-
ing group on fracture to request for updates on secular trends in
hip and other OP fracture incidence rates (IRs) [22]. In Danish
studies, age-adjusted hip fracture IRs increased between 1977
and 1999, yet a decline, particularly in women, has been ob-
served since 1997 [23–25]. This trend of increasing fractures up
to the 1990s, with a leveling of fracture rates in the past two
decades, has been noted by others [18, 19, 26]. Apart from two
single year studies which surveyed the IRs of forearm and OP
fractures in 2010 and 2011, respectively, and two reports on hip
fracture trend until 2006 and 2010, there has never been a
country-specific report on secular incidence trends in all OP
fractures for Denmark [24, 25, 27, 28]. Thus, the aim of this
study was to investigate the IRs of MOF among adults aged
50 years or older in Denmark over the period 1995–2010.
Methods
Data source
We used data from the registry of the Danish National Health
Service. The extensive registers in Denmark cover all contacts
to the health sector for all citizens, without age restriction.
This includes approximately 5.2 million individuals in 1995
and 5.5 million in 2010 [29]. The unique 10-digit civil registry
number allocated to each Danish citizen was used to link the
population-based registries and generate a complete hospital
discharge history for each patient. Data on vital status for the
Danish population have been collected since 1968 in the Civil
Registration System, and all inpatient contacts have been reg-
istered in the Danish National Hospital Discharge Register
(NHDR) since 1977 [30]. The NHDR covers all inpatient
contacts since 1977, and beginning in 1995, the NHDR cap-
tures also all outpatient visits to hospitals, outpatient clinics,
and emergency room visits. The validity of the Danish
National fracture records have been previously verified [31].
Study design
We included patients, aged 50 years or older, who were diag-
nosed with a fracture in the period between 1995 and 2010.
MOF were identified in accordance with the WHO/FRAX
definition as hip, clinical symptomatic vertebral, humerus, or
forearm (radius/ulna) fracture [32, 33]. Theywere clustered by
site using the following International Classification of
Diseases and Related Health Problems 10th Edition (ICD-
10) codes: hip (S72.0-S72.2), clinical symptomatic vertebral
(S12, S22.0, S22.1, S32.0, T08), humerus (S42.2-S42.4), and
forearm (S52). As it is possible that the original fracture and
follow-up visits or procedures may have the same ICD-10
code, we introduced a washout period to avoid double
counting fractures in individuals. As 1995 was the first year
of observation, we also applied a 1-year washout period prior
to 1995. Thus, if a patient had a hip fracture code (ICD-10
S72.2) in 1995 and also had the same code in 1994, we did not
include this in our analysis as we could not be certain that it
was a new hip fracture or a recurring follow-up. After 1995,
we took the first recorded fracture code in each calendar year
and assessed if the patient had a previous code for the same
fracture, or unspecified fracture, in the prior 365 days. If there
were no codes for a prior fracture of the same type, or unspec-
ified, in the prior 365 days, it was deemed an eligible new
fracture, otherwise it was excluded. Additionally, for MOF,
the first occurrence of a hip, clinical symptomatic vertebral,
humerus, or forearm fracture was selected.
Statistical analysis
Population demographics for the background population in cal-
endar years 1995–2010 were obtained online from Statistics
Denmark [29]. IRs (number of fractures/10,000 person years
[PYs]), and corresponding 95% confidence intervals (95% CI),
were calculated by dividing all cases of first recorded fractures
during the calendar year over the average number of persons
alive in that calendar year. For example, to calculate the denom-
inator for the year 2010, we first summed the number of people
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alive on 1 January 2010 and those alive on 1 January 2011, then
divided this sum by two. Gender-specific IRs were estimated in
addition to site-specific fracture rates. While we did not produce
age-specific rates, we were able to standardize the IRs to the
annual Danish population over the age 50, using the Statistics
Denmark data. This permits a comparison to a similar age distri-
bution. Women-to-men incidence rate ratios (IRRs) were calcu-
lated for MOF and determined by dividing the IR for women
over the IR for men. The IRs were plotted over time both for
MOF, as well as specific fracture sites, and the plots were exam-
ined by visual assessment. Data were analyzed using SAS ver-
sion 9.3 (SAS Institute Inc. Cary, NC, USA).
Results
We identified a total of 422,380MOF in Danish adults over 50
between 1995 and 2010, where a sum of 101,177 fractures
occurred among men, and 321,203 cases among women
(Table 1); thus, females sustained 76.0% of all MOF. There
was a 4.5% relative increase in the total number of MOF from
1995 to 2010, although apart from a spike in 2010, the num-
bers were dropping until 2009. The mean age at first occur-
rence of a MOF was 74.1 years, and the age distribution was
constant across all years.
A general decline was observed in the IRs of MOF for the
whole population, where IRs dropped from 169.8 per 10,000
PYs in 1995 to 148.0 in 2010 (Table 1), as visualized in Fig. 1.
Among women, the rates for theMOF dropped during this 16-
year study period from 242.8 to 211.5; however, it is worth
mentioning that the rates had dropped even lower in the years
2008 and 2009 (IRs 188.3 and 186.2, respectively). For men,
the MOF rates exhibited a smaller decrease from 82.9 in 1995
to 77.6 in 2010. The women-to-men rate ratio of MOF de-
creased noticeably from 2.93 (95% CI, 2.85–3.01) in 1995 to
2.72 (95% CI, 2.65–2.80) in 2010 (Table 1).
Regarding hip fractures, a total of 152,571 cases were iden-
tified, where 72.3% (110,349) of all hip fractures occurred in
women, and 27.7% (42,222) occurred in men. The mean age
for occurrence of hip fracture among the whole population
was 80.0 years. The overall hip fracture IRs decreased during
the study period, i.e., 1995 to 2010 from 64.1 per 10,000 PYs
to 45.5, respectively, and this decrease was more prominent in
women (Fig. 2a). We observed a 31% decline in hip fracture
rates (from 87.2 to 59.9 per 10,000 PYs) among women and
19% decline (from 36.5 to 29.6 per 10,000 PYs) among men.
The IRs over time for the other MOF subsites are provided
in Fig. 2b–d. The trend for clinical vertebral fracture remained
steady between 1995 and 2010, yet there was a slightly de-
creasing trend for women and an increasing trend for men
Table 1 Absolute number and incidence rates of major osteoporotic fractures among Danish adults aged 50+, stratified by sex and calendar year
(1995–2010)
Calendar
year
Total Men Women IRRW/M ratio
Number
of
fractures
IR per
10,000
PYs
95%
CI
Number
of
fractures
IR per
10,000
PYs
95%
CI
Number
of
fractures
IR per
10,000
PYs
95%
CI
IRR
W/
M
95%
CI
1995 28,351 169.8 166.9 172.6 6323 82.9 80.0 85.9 22,028 242.8 238.2 247.4 2.93 2.85 3.01
1996 27,215 160.1 157.4 162.9 5908 75.8 73.1 78.6 21,307 231.5 227.1 236.0 3.05 2.97 3.14
1997 25,856 149.5 146.9 152.2 5850 73.5 70.9 76.3 20,006 214.3 210.1 218.6 2.91 2.83 3.00
1998 25,823 147.1 144.6 149.7 5850 72.2 69.6 74.9 19,973 211.3 207.1 215.5 2.93 2.84 3.01
1999 26,314 148.1 145.5 150.7 6141 74.7 72.1 77.4 20,173 211.3 207.1 215.5 2.83 2.75 2.91
2000 25,007 139.2 136.8 141.7 5925 71.1 68.6 73.7 19,082 198.1 194.1 202.2 2.79 2.71 2.87
2001 25,797 142.1 139.7 144.6 6004 71.1 68.6 73.7 19,793 203.8 199.8 207.9 2.87 2.78 2.95
2002 25,698 140.2 137.8 142.7 6211 72.7 70.2 75.3 19,487 199.3 195.3 203.3 2.74 2.66 2.82
2003 25,192 136.1 133.7 138.5 6198 71.6 70.0 75.2 18,994 192.7 188.8 196.7 2.69 2.61 2.77
2004 26,196 140.0 137.6 142.5 6446 73.6 71.0 76.2 19,750 198.6 194.7 202.6 2.70 2.63 2.78
2005 26,687 141.1 138.7 143.5 6603 74.4 71.8 77.0 20,084 200.2 196.2 204.2 2.69 2.62 2.77
2006 26,739 139.8 137.4 142.2 6558 72.8 70.4 75.4 20,181 199.2 195.4 203.2 2.74 2.66 2.81
2007 25,804 133.4 131.1 135.7 6538 71.6 69.2 74.2 19,266 188.5 184.7 192.3 2.63 2.56 2.71
2008 26,001 132.9 130.6 135.2 6569 71.0 68.6 73.5 19,432 188.3 184.6 192.2 2.65 2.58 2.73
2009 26,076 131.8 129.5 134.1 6681 71.3 68.9 73.8 19,395 186.2 182.5 190.0 2.61 2.54 2.69
2010 29,624 148.0 145.6 150.4 7372 77.6 75.1 80.2 22,252 211.5 207.5 215.5 2.72 2.65 2.80
Total 422,380 101,177 321,203
IR incidence rate, CI confidence interval, IRRW/M women-to-men ratio of incidence rate, PYs person years
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(Fig. 2b). Overall, humerus fracture rates remained stable, and
this steady state was observed among both men and women
(Fig. 2c). Regarding forearm fractures, there is a declining
trend for the whole study population from 1995 to 2009 (IRs
dropped from 73.0 in 1995 to 55.5 in 2009), but there was a
spike in 2010 (IRs 69.1) (Fig. 2d). Women followed a similar
trend to the overall trend regarding radius/ulna fracture, while
for men, a smaller decrease was observed. The mean age of
occurrence was 72.4 years for clinical vertebral fracture,
73.6 years for humerus fracture, and 69.6 years for radius/
ulna fracture. Furthermore, females sustained 61.5% of all
clinical vertebral fractures, 76.4% of all humerus fractures,
and 82.1% of all radius/ulna fractures.
Discussion
In this study, we observed a reduction in IRs of MOF from
1995 to 2010 in 50+ adults in Denmark, where the striking
finding was a reduction in hip fracture rates in both men and
women. Among women, the IRs of all MOF have been de-
clining, with exception of a rather steady state for humerus.
But in men, apart from the gradually reducing hip and forearm
fracture rates, steady rates for humerus fracture and a rising
trend in vertebral fracture were noticed. The results of study
by Driessen et al. in 2011 complement our observed decreas-
ing trend in MOF for Denmark [28]. Considering the aging
population, these findings are interesting, as we identify a
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decreasing incidence of MOF between 1995 and 2011. Yet,
importantly, there appears to be differences between males
and females, particularly for hip fractures, in Denmark.
In general, our findings are in line with the present literature
affirming a decrease in hip fracture rates in bothmen andwomen.
We observed a 31% decline (from 87.2 to 59.9 per 10,000 PYs)
amongwomen and 19%decline (from 36.5 to 29.6) amongmen.
Driessen et al. estimated even lower IRs for hip fracture in
Denmark in the year 2011, as 57.1 per 10,000 PYs for women,
and 29.2 for men [28]. In numerous studies from different coun-
tries, a leveling or decrease in age- and sex-specific hip fracture
rates especially in the past two decades has been noticed too
[16–21, 24]. For instance, Leslie et al. showed that there was a
32% reduction in hip fracture rates among women in Canada
(118.6 to 80.9 per 100,000 PYs), and 25% in men (68.2 to
51.1) between 1985 and 2005 [16]. Additionally, Brauer et al.
reported dropped rates from 964.2 per 100,000 PYs in 1986 to
793.5 in 2005 among 65+ women, and from 392.4 to 369.0
among 65+ men in the USA [17]. In most cases as we observed,
the decrease was more profound among women, which could be
hypothesized due to the higher number of women under anti-
osteoporosis treatment or who received lifestyle modifications.
There are few studies that have looked at both hip and other
MOF. A study in the USA made comparisons after 20 years
(1989–1991 and 2009–2011), and the reported decrease in hip
fracture rates in both sexes and an increase in vertebral frac-
tures in men were concordant with our results [34]. Another
study in Canada (1986–2006) identified a similar result to ours
regarding a global decrease in hip fracture rates and a decrease
of forearm fractures among women [35].
On the other hand, there are studies whose results are not
concordant with our findings. Van der Velde et al. reported an
increase of hip fracture rates in men and a steady state for
women in the UK [15]; the differences could be due to a
different version of ICD used for fracture classification
(ICD-9 vs. 10) or a different kind of database (medical
record-based Clinical Practice Research Datalink [CPRD]).
A Japanese study showed not only substantially lower rates
for limb OP fractures, and higher rates of vertebral cases, but
also an increasing trend in hip fractures since the 1990s [36].
Two other studies from Japan and Singapore showed similar
results with increasing tendencies for hip fracture over the
1990s and 2000s [37, 38]. Interestingly, there was a notable
difference between East andWest regarding change of rates of
hip fracture in the past decades, where the exact reason for
these trend discrepancies is not clear [39, 40].
Our study period (i.e., the 1990s and 2000s)was a crucial time
span as it saw extensive developments in management of osteo-
porosis, including bisphosphonates coming to themarket, aware-
ness of osteoporosis management grew, and treatment guidelines
underwent a number of revisions [41, 42]. Based on the guide-
lines for osteoporosis treatment in Denmark, the suggested daily
intake of calcium for men with osteoporosis is lower than
postmenopausal women at risk (800–1000 mg vs. 1000–
1200 mg, respectively), but the first line treatment for both sexes
is alendronate, and in case of severe disease, anabolic treatment is
indicated [43, 44]. Nevertheless, osteoporosis has been tradition-
ally considered a women’s only disease, and it could be hypoth-
esized that a decrease in hip fractures due to preventive medica-
tionmay be stronger amongwomen thanmen.Numerous studies
have already shown the effectiveness of anti-osteoporotic therapy
(including bisphosphonates) on fracture prevention; however,
there are studies which reported only a small role of these med-
ication in the reduction of hip fracture rates [24, 45–47]. So, the
extent to which anti-osteoporotic therapy may affect rates of OP
fractures, or whether it could have a role in the present discrep-
ancies among men and women, requires further investigation.
Beside anti-osteoporotic therapy, there might be other factors
which contributed to the mostly declining OP fracture trend in
Denmark. An increasing proportion of 50+ individuals was born
after theWorldWar II, and grew up under better nutritional states
and physical activities (sport classes introduced at schools, etc.),
which might help to improve their peak bone mass. Also, the
next generations are being guided by physicians on the impor-
tance of bone health as we age, and this could end up in positive
effects including better use of Ca/Vit D supplements, and more
adherence to anti-osteoporotic therapies. These among others
resulted in a lower rate of fracture despite an aging population.
Still, interventions such as more ubiquitous use of devices that
reduce risk of falling in frail and elderly, such as walk aids, could
play a role. These hypothesized factors are beyond the scope of
this study and need further investigation.
As stated above, the economic burden of OP fractures is sub-
stantial andmany reports suggest this will increase over the com-
ing yearsmostly because of an aging population [2, 4–9]. Studies
showed that healthcare expenditures associated with an OP frac-
ture in theUSAare twice ashighcompared topatientsonly affect-
ed with osteoporosis and are threefold higher compared to the
general population [9]. It has also been shown that the hospital
costs of OP fractures were higher compared to similar aging ail-
ments likemyocardial infarction,stroke,orbreastcancer[5].From
€1.6 billion total costs of OP fractures in Denmark in 2011, just
€628 million (40.2%) was spent for men [10]; but based on our
results, there was an increase in the total number of fractures in
Denmark, theOP fracture rates are not declining amongmenwith
the same rate observed inwomen, and thewomen tomen ratio for
MOF rates were noticeably decreased from 2.93 to 2.72 between
1995 and 2010. Considering all these, it could be expected that
healthcare expenditures for osteoporosis andOP fractures among
menmight be amore serious burden in the near future.
This study hadmany strengths. The database used provided
the opportunity of studying all fracture cases reported to hos-
pitals in Denmark in this time period, and it has already proved
to be reliable and valid [31]. This is one of the few studies that
examined not only hip but all MOF. Again, the duration of
study is one of the longest in literature with 16 years of follow-
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up time. We were also able to stratify IRs by fracture sites. All
these resulted in a comprehensive study that could be used for
national and international policy-making purposes, including
improvements of healthcare services, and better estimation of
OP fracture-associated costs.
We had also some limitations in this study. To minimize
double counting, we excluded fractures of the same type with-
in 1 year. While this decision was made to improve the like-
lihood that we would capture new fractures as opposed to
follow-up visits, we recognize that this may have resulted in
an underestimation of the true fracture rate as we may have
excluded some new fractures. In case of clinical vertebral
fracture, this underestimation could be even worse, as the
evidence suggests the majority of vertebral fractures do not
immediately come to clinical attention [48]. On the other
hand, there is this possibility that we overestimated the clinical
vertebral fractures, because with advancement of spine imag-
ing utilization in recent years, there are more chances to detect
old previously unrecognized fractures, and so, some prevalent
vertebral fracture might be misclassified as incident fractures.
Also, our IRs were not adjusted beyond the factors explained
in this article, as we were not able to examine the influence of
any further mediating or confounding factor on the observed
trends. Similarly, we have limited explanatory information for
seemingly anomalous spikes. For example, the only explana-
tion for the spike observed in trends of radius/ulna fracture in
the year 2010 (Fig. 2d) was the record-breaking freezing win-
ter happened in Europe in 2010 (potentially resulting in higher
number of falls) [49], as no other coding or reporting issue was
detected.
In conclusion, we did a series of cross-sectional analyses
showing the secular trends of MOF rates in Denmark between
1995 and 2010. The results showed a general decline in MOF
rates and a decreasing trend in hip fracture rates for both men
and women, which is in line with the study by Driessen et al.
in Denmark for the year 2011, and many other studies in
Nordic and Western countries. Also, we noticed a lower rate
of decrease of hip fracture trends and an increasing trend in
rates of vertebral fracture among men, which was accompa-
nied by a reducing women-to-men IRs ratio in the study peri-
od. Considering these observations and the major economic
burden that accompanies this devastating disease, more atten-
tion should be paid to MOF, especially in men.
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